GLPwatch
Glucagon-like peptide-1 (GLP-1) receptor agonists in type 2 diabetes and long-term complications: FOCUS on retinopathy.
Diabet Med · 2021
Last updated 2026-05-28| Journal | Diabet Med, 2021 |
|---|---|
| Citations | 8 |
| Relative citation ratio | 0.54 |
| NIH percentile | 31 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Full record and abstract on PubMed 32799379 ↗